Earnings

Aprea Therapeutics Q3 EPS $(0.09) Misses $(0.07) Estimate

Nov 4, 2026 · 08:36 AM ET· updated 1h ago

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 80.85 percent increase over losses of $(0.47) per share

Why It Matters

Aprea lost more money per share than experts thought it would. But the company is losing less money than it did last year, which shows progress.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

APRE0.52

+0.03 (+5.62%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.